Exact Sciences Corp (NASDAQ:EXAS)

110.60
Delayed Data
As of May 05
 -5.37 / -4.63%
Today’s Change
70.75
Today|||52-Week Range
159.54
-16.52%
Year-to-Date
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Margins Down
May 05 / Zacks.com - Paid Partner Content
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
May 04 / Zacks.com - Paid Partner Content
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
May 05 / MotleyFool.com - Paid Partner Content
3 High-Growth Stocks on Cathie Wood's Buy List Last Week
Apr 25 / MotleyFool.com - Paid Partner Content
Exact Sciences (EXAS) Q1 2021 Earnings Call Transcript
May 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close116.02
Today’s open117.56
Day’s range109.73 - 119.55
Volume2,443,348
Average volume (3 months)1,610,143
Market cap$22.6B
Data as of 4:10pm ET, 05/05/2021

Growth & Valuation

Earnings growth (last year)-777.37%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+70.19%
P/E ratioNM
Price/Sales13.43
Price/Book7.44

Competitors

----
TECHBio-Techne Corp-1.42-0.34%
ZLABZai Lab Ltd-4.55-2.92%
BMRNBiomarin Pharmaceuti...-0.67-0.86%
Data as of 4:12pm ET, 05/05/2021

Financials

Next reporting dateAugust 4, 2021
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$1.5B
Annual profit (last year)-$848.5M
Net profit margin-56.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Madison, Wisconsin

Forecasts